Track the Sulaiman Alhabib stock price and the full insider trade history of the company, a listed equity based in Saudi Arabia. Shares are quoted on the SA market, under the supervision of Tadawul (CMA). Operating in the Health Care sector, Sulaiman Alhabib has recorded 3 insider filings. Market capitalisation: €74.3bn. The latest transaction was filed on 8 October 2023 (Board / executive change). All data is free.
Analysts rate Sulaiman Alhabib Buy (bullish), based on 15 analysts. Average price target: SAR 268.88.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Sulaiman Alhabib is a company operating in the healthcare and pharmaceutical sector. It is listed on the XSAU market.